DJS Antibodies, Ltd.

The development path for better idiopathic pulmonary fibrosis (IPF) treatments is strewn with failures but Bristol Myers Squibb Company is hoping for a more successful journey on the back of positiv

The trend of promising UK drugmakers being acquired for millions of dollars by US majors continued apace last year – a sign, some would argue, that the country's biotech sector will never develop into

Who: AbbVie Inc. . and DJS Antibodies What: AbbVie will acquire DJS Antibodies, a private UK biotech focused on developing antibodies against hard-to-drug targets. Why: With the acquisition, Ab